Literature DB >> 33514459

Rationalizing Random Walks: Replicating Protective Antibody Trajectories.

Jennifer L Remmel1, Margaret E Ackerman2.   

Abstract

'Reverse vaccinology 2.0' aims to rationally reproduce template antibody responses, such as broadly neutralizing antibodies against human immunodeficiency virus-1. While observations of antibody convergence across individuals support the assumption that responses may be replicated, the diversity of humoral immunity and the process of antibody selection are rooted in stochasticity. Drawing from experience with in vitro antibody engineering by directed evolution, we consider how antibody selection may be driven, as in germline-targeting vaccine approaches to elicit broadly neutralizing antibodies and illustrate the potential consequences of over-defining a template antibody response. We posit that the prospective definition of template antibody responses and the odds of replicating them must be considered within the randomness of humoral immunity.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antibody engineering; antibody selection; directed evolution; germline targeting; rational vaccine design; reverse vaccinology

Year:  2021        PMID: 33514459      PMCID: PMC7914221          DOI: 10.1016/j.it.2021.01.001

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  88 in total

Review 1.  Rational antibody-based HIV-1 vaccine design: current approaches and future directions.

Authors:  Laura M Walker; Dennis R Burton
Journal:  Curr Opin Immunol       Date:  2010-03-17       Impact factor: 7.486

2.  Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Bryan S Briney; Scott A Smith; Christopher F Basler; James E Crowe
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

3.  Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.

Authors:  Johannes F Scheid; Hugo Mouquet; Beatrix Ueberheide; Ron Diskin; Florian Klein; Thiago Y K Oliveira; John Pietzsch; David Fenyo; Alexander Abadir; Klara Velinzon; Arlene Hurley; Sunnie Myung; Farid Boulad; Pascal Poignard; Dennis R Burton; Florencia Pereyra; David D Ho; Bruce D Walker; Michael S Seaman; Pamela J Bjorkman; Brian T Chait; Michel C Nussenzweig
Journal:  Science       Date:  2011-07-14       Impact factor: 47.728

4.  Convergent antibody signatures in human dengue.

Authors:  Poornima Parameswaran; Yi Liu; Krishna M Roskin; Katherine K L Jackson; Vaishali P Dixit; Ji-Yeun Lee; Karen L Artiles; Simona Zompi; Maria José Vargas; Birgitte B Simen; Bozena Hanczaruk; Kim R McGowan; Muhammad A Tariq; Nader Pourmand; Daphne Koller; Angel Balmaseda; Scott D Boyd; Eva Harris; Andrew Z Fire
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

5.  Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition.

Authors:  Frederic A Fellouse; Christian Wiesmann; Sachdev S Sidhu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

6.  Initial mutations direct alternative pathways of protein evolution.

Authors:  Merijn L M Salverda; Eynat Dellus; Florien A Gorter; Alfons J M Debets; John van der Oost; Rolf F Hoekstra; Dan S Tawfik; J Arjan G M de Visser
Journal:  PLoS Genet       Date:  2011-03-03       Impact factor: 5.917

7.  Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.

Authors:  Yunlong Cao; Bin Su; Xianghua Guo; Wenjie Sun; Yongqiang Deng; Linlin Bao; Qinyu Zhu; Xu Zhang; Yinghui Zheng; Chenyang Geng; Xiaoran Chai; Runsheng He; Xiaofeng Li; Qi Lv; Hua Zhu; Wei Deng; Yanfeng Xu; Yanjun Wang; Luxin Qiao; Yafang Tan; Liyang Song; Guopeng Wang; Xiaoxia Du; Ning Gao; Jiangning Liu; Junyu Xiao; Xiao-Dong Su; Zongmin Du; Yingmei Feng; Chuan Qin; Chengfeng Qin; Ronghua Jin; X Sunney Xie
Journal:  Cell       Date:  2020-05-18       Impact factor: 41.582

8.  Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model.

Authors:  James E Voss; Raiees Andrabi; Laura E McCoy; Natalia de Val; Roberta P Fuller; Terrence Messmer; Ching-Yao Su; Devin Sok; Salar N Khan; Fernando Garces; Laura K Pritchard; Richard T Wyatt; Andrew B Ward; Max Crispin; Ian A Wilson; Dennis R Burton
Journal:  Cell Rep       Date:  2017-10-03       Impact factor: 9.423

9.  Convergent antibody responses to SARS-CoV-2 in convalescent individuals.

Authors:  Davide F Robbiani; Christian Gaebler; Frauke Muecksch; Julio C C Lorenzi; Zijun Wang; Alice Cho; Marianna Agudelo; Christopher O Barnes; Anna Gazumyan; Shlomo Finkin; Thomas Hägglöf; Thiago Y Oliveira; Charlotte Viant; Arlene Hurley; Hans-Heinrich Hoffmann; Katrina G Millard; Rhonda G Kost; Melissa Cipolla; Kristie Gordon; Filippo Bianchini; Spencer T Chen; Victor Ramos; Roshni Patel; Juan Dizon; Irina Shimeliovich; Pilar Mendoza; Harald Hartweger; Lilian Nogueira; Maggi Pack; Jill Horowitz; Fabian Schmidt; Yiska Weisblum; Eleftherios Michailidis; Alison W Ashbrook; Eric Waltari; John E Pak; Kathryn E Huey-Tubman; Nicholas Koranda; Pauline R Hoffman; Anthony P West; Charles M Rice; Theodora Hatziioannou; Pamela J Bjorkman; Paul D Bieniasz; Marina Caskey; Michel C Nussenzweig
Journal:  Nature       Date:  2020-06-18       Impact factor: 69.504

10.  B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.

Authors:  Deli Huang; Robert K Abbott; Colin Havenar-Daughton; Patrick D Skog; Rita Al-Kolla; Bettina Groschel; Tanya R Blane; Sergey Menis; Jenny Tuyet Tran; Theresa C Thinnes; Sabrina A Volpi; Alessia Liguori; Torben Schiffner; Sophia M Villegas; Oleksandr Kalyuzhniy; Mark Pintea; James E Voss; Nicole Phelps; Ryan Tingle; Alberto R Rodriguez; Greg Martin; Sergey Kupryianov; Allan deCamp; William R Schief; David Nemazee; Shane Crotty
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-01       Impact factor: 12.779

View more
  3 in total

1.  Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers.

Authors:  Alessandra Gallinaro; Maria Franca Pirillo; Yoann Aldon; Serena Cecchetti; Zuleika Michelini; Antonella Tinari; Martina Borghi; Andrea Canitano; Paul F McKay; Roberta Bona; Maria Fenicia Vescio; Felicia Grasso; Maria Blasi; Silvia Baroncelli; Gabriella Scarlatti; Celia LaBranche; David Montefiori; Mary E Klotman; Rogier W Sanders; Robin J Shattock; Donatella Negri; Andrea Cara
Journal:  NPJ Vaccines       Date:  2022-04-21       Impact factor: 9.399

2.  Individualized VDJ recombination predisposes the available Ig sequence space.

Authors:  Philippe A Robert; Victor Greiff; Andrei Slabodkin; Maria Chernigovskaya; Ivana Mikocziova; Rahmad Akbar; Lonneke Scheffer; Milena Pavlović; Habib Bashour; Igor Snapkov; Brij Bhushan Mehta; Cédric R Weber; Jose Gutierrez-Marcos; Ludvig M Sollid; Ingrid Hobæk Haff; Geir Kjetil Sandve
Journal:  Genome Res       Date:  2021-11-23       Impact factor: 9.043

3.  Application of IgG antibody titer and subtype in diagnosis and severity assessment of hemolytic disease of the newborn.

Authors:  Zijun Ding; Xinhua Zhang; Hai Li
Journal:  Transl Pediatr       Date:  2022-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.